2017
DOI: 10.22608/apo.2017416
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Age-Related Macular Degeneration

Abstract: Age-related macular degeneration (AMD) compromises quality of life. However, the available therapeutic options are limited. This has led to the identification of modifiable risk factors to prevent the development or alter the natural course and prognosis of AMD. The identification and modification of risk factors has the potential for greater public health impact on reducing morbidity from AMD. Likewise, identifying the imaging clues and genetic clues could serve as a guide to recognizing the propensity for pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 72 publications
0
2
0
Order By: Relevance
“…Following the invention of bevacizumab, a variety of VEGF-VEGFR targeted agents come out. Apart from anti-VEGF mAb, there are other three approaches to inhibit VEGF-VEGFR signaling pathway: (I) decoy VEGF-trap receptor such as aflibercept [46]; (II) anti-VEGFR2 mAb such as ramucirumab [47]; (III) tyrosine kinase inhibitor (TKI) which interferes intracellular signal transduction of VEGF such as axitinib, sorafenib, sunitinib, and vatalanib [4851]. Moreover, based on chimeric antigen receptor (CAR) T cell technology, Chinnasamy et al developed anti-VEGFR2 CAR T cell to retard tumor growth [52].…”
Section: Anti-angiogenesis Agents: the Natural Ally Of Icimentioning
confidence: 99%
“…Following the invention of bevacizumab, a variety of VEGF-VEGFR targeted agents come out. Apart from anti-VEGF mAb, there are other three approaches to inhibit VEGF-VEGFR signaling pathway: (I) decoy VEGF-trap receptor such as aflibercept [46]; (II) anti-VEGFR2 mAb such as ramucirumab [47]; (III) tyrosine kinase inhibitor (TKI) which interferes intracellular signal transduction of VEGF such as axitinib, sorafenib, sunitinib, and vatalanib [4851]. Moreover, based on chimeric antigen receptor (CAR) T cell technology, Chinnasamy et al developed anti-VEGFR2 CAR T cell to retard tumor growth [52].…”
Section: Anti-angiogenesis Agents: the Natural Ally Of Icimentioning
confidence: 99%
“…We modified a quantitative Food Frequency Questionnaire (FFQ) to assess the intake of the following food groups rich in nutrients considered important in the AMD aetiology and oxidative processes to evaluate the participants’ dietary habits: fatty fish, eggs, green vegetables, fruit and fruit juice, omega-3-rich oils, simple and complex carbohydrates, as recommended previously [ 11 , 13 , 33 , 34 ]. Three different frequencies in terms of portions per week were available for selection for each food type and alcoholic drink as follows: fatty fish: <1, 2–4, and >4; eggs: <1, 2–4, and >4; green vegetables: <2, 2–7, and >7; fruit and fruit juice: <2, 2–7, and >7; omega-3-rich oils: <2, 2–7, and >7; simple carbohydrates: <2, 2–7, and >7; complex carbohydrates: <2, 2–7, and >7; beer: 0, ≤1, and 2–7; wine: 0, <2, and 2–7; and vodka: 0, ≤1, and 2–3.…”
Section: Methodsmentioning
confidence: 99%